A Phase I Study of Systemic Gene Therapy With SGT-94 in Patients With Solid Tumors (SGT94-01)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2014 by SynerGene Therapeutics, Inc.
Sponsor:
Information provided by (Responsible Party):
SynerGene Therapeutics, Inc.
ClinicalTrials.gov Identifier:
NCT01517464
First received: January 17, 2012
Last updated: May 2, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2015
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)